IQ4I Research & Consultancy Published a New Report on "Vascular and Non-Vascular Stents": Estimated to be Worth $12.4 Billion by 2021
The global vascular and non-vascular market is expected to reach $12.4 billion by 2021. This report analyzes the stent market in terms of market revenue ($ million) for all segments.
Albany, NY, October 16, 2015 --(PR.com)-- IQ4I’s Report Contains 155 market data tables and 38 figures spread through 349 pages and an exhaustive TOC on “Vascular and Non-Vascular Stents Global Market [Types (Bare metal, Drug eluting, Bio-resorbable & other stents); Applications (Vascular stents {Coronary & Peripheral} & Non-vascular stents {Gastrointestinal, Airway, Urology, Ophthalmology & Others}); Materials (Metals stents {Cobalt Chromium, Nickel-Titanium Alloy, Platinum-Chromium, Stainless Steel & Others} & Polymers stents {Durable & Bio-absorbable}); Coatings (Coated {Inorganic, Polymer, Polymer free & Others} & Non-coated stents); Regional (North America, Europe, Asia Pacific and Rest of the World)]
The global vascular and non-vascular market is expected to reach $12.4 billion by 2021. This report analyzes the stent market in terms of market revenue ($ million) for all segments.
Stents are devices used in the body for treating weak or narrow blood vessels due to plaque formation. Stents help in the improvement of the blood flow and prevents the blood vessels from bursting. Increased preferences of minimally-invasive procedures, growing aging populations, increasing incidence of metabolic diseases, technological advancements in stent technologies such as bio-degradable polymer and polymer-free coated stents, bio-resorbable vascular scaffold (BVS) and improvement in healthcare infrastructure and services are driving the growth of the market.
Slashing prices of stents, less adoption and side effects associated with stenting procedures such as allergic reactions, in-stent restenosis and stent thrombosis are hampering the market growth.
North America accounted for the largest share in 2014 due to the introduction of new technologies by leading players, growing awareness and increased prevalence of arterial diseases and Asia-pacific region is expected to grow at the highest CAGR during the forecast period 2015 to 2021 due to government initiatives for modernization of healthcare infrastructure, and increasing focus of both international and domestic players on the stents market.
The global stents market is a highly competitive market and all the existing players in this market are involved in developing new and advanced products to maintain their market shares. Some of the key players of the stents market are Abbott laboratories (U.S.), B.Braun (Germany), Biosensors (Singapore), Boston scientific (U.S.), Cordis Corporation (U.S.), Medtronic (Ireland), Olympus (Japan), Microport (China), Terumo (Japan), Biotronik (Germany) Cook Medical (U.S) and C.R.Bard (U.S.).
Reasons for buying this report:
· Market assessment of all segments and sub segments of Stents market
· In-depth market sizing analysis of various segments and sub segments of Types, Coatings, Materials, Applications and Regional markets
· Regulatory scenario across the globe
· Reimbursement Scenario
· Supply Chain Analysis
· Upcoming Technologies
· Patent Analysis
· Market share analysis of key players
The global vascular and non-vascular market is expected to reach $12.4 billion by 2021. This report analyzes the stent market in terms of market revenue ($ million) for all segments.
Stents are devices used in the body for treating weak or narrow blood vessels due to plaque formation. Stents help in the improvement of the blood flow and prevents the blood vessels from bursting. Increased preferences of minimally-invasive procedures, growing aging populations, increasing incidence of metabolic diseases, technological advancements in stent technologies such as bio-degradable polymer and polymer-free coated stents, bio-resorbable vascular scaffold (BVS) and improvement in healthcare infrastructure and services are driving the growth of the market.
Slashing prices of stents, less adoption and side effects associated with stenting procedures such as allergic reactions, in-stent restenosis and stent thrombosis are hampering the market growth.
North America accounted for the largest share in 2014 due to the introduction of new technologies by leading players, growing awareness and increased prevalence of arterial diseases and Asia-pacific region is expected to grow at the highest CAGR during the forecast period 2015 to 2021 due to government initiatives for modernization of healthcare infrastructure, and increasing focus of both international and domestic players on the stents market.
The global stents market is a highly competitive market and all the existing players in this market are involved in developing new and advanced products to maintain their market shares. Some of the key players of the stents market are Abbott laboratories (U.S.), B.Braun (Germany), Biosensors (Singapore), Boston scientific (U.S.), Cordis Corporation (U.S.), Medtronic (Ireland), Olympus (Japan), Microport (China), Terumo (Japan), Biotronik (Germany) Cook Medical (U.S) and C.R.Bard (U.S.).
Reasons for buying this report:
· Market assessment of all segments and sub segments of Stents market
· In-depth market sizing analysis of various segments and sub segments of Types, Coatings, Materials, Applications and Regional markets
· Regulatory scenario across the globe
· Reimbursement Scenario
· Supply Chain Analysis
· Upcoming Technologies
· Patent Analysis
· Market share analysis of key players
Contact
IQ4I Research & Consultancy Pvt. Ltd.
Satish Birudukota
+91 8060500229
iq4i.com
Satish Birudukota
+91 8060500229
iq4i.com
Contact
Categories